NOUVEAU: recomDot Borrelia IgG, IgM - ImmunoBlot en 96 puits ELISA plaque

Intro tekst

Nous sommes heureux d’annoncer le premier test de notre nouvelle gamme de produits Mikrogen, recomDot. La nouvelle technologie de puces protéiques combine la grande valeur informative des tests d'immunoblot avec un traitement simple et automatisé sur des instruments ELISA standard. Le système de test est idéal pour les besoins élevés en temps réduit.

Afbeelding

Introduction of a novel easy-to-use microarray for Borrelia diagnostics
Julia Schamberger, Stefan Ammer, Michael Mayer, Torsten Pirch, Angela Eser, Ingrid Albrecht-Walz, Friedhelm Struck, Karin Wochinz-Richter, Kerstin Wagner, Oliver Böcher, Erwin Soutschek

Mikrogen GmbH, Neuried, Germany

The new recomDot Borrelia is based on recombinant, highly specific, immunodominant and phase-specific antigens of the five human-pathogenic Borrelia species. Tentative diagnoses and suspected disease stages of patient samples found borderline or positive in screening can be substantiated by means of typical IgG and IgM antibody constellations.

The recomDot Borrelia protein microarray combines the high informative value of the Line immunoassay with easy, automated processing on standard ELISA instruments.

Results Dot.JPG

Conclusion

• The recomDot Borrelia is highly sensitive and specific for the detection of antibodies against Borrelia burgdorferi ssp. Cross-reactivity turned out to be very low, accuracy of the recomDot has been shown to be excellent.
• The recomDot Borrelia is a fast, easy-to-use and a more economical alternative to conventional methods confirming screening results.

Telechargez le poster